Suppr超能文献

他汀类药物治疗患者中发生多种药物相互作用的可能性:来自日本不良药物事件报告(JADER)数据库的数据分析及动物实验验证。

Possibility of Multiple Drug-Drug Interactions in Patients Treated with Statins: Analysis of Data from the Japanese Adverse Drug Event Report (JADER) Database and Verification by Animal Experiments.

机构信息

Laboratory of Analytical Pharmaceutics and Informatics, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan.

Laboratory of Pharmacy Management, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan.

出版信息

Int J Med Sci. 2022 Oct 9;19(12):1816-1823. doi: 10.7150/ijms.76139. eCollection 2022.

Abstract

Adverse drug events due to drug-drug interactions can be prevented by avoiding concomitant use of causative drugs; therefore, it is important to understand drug combinations that cause drug-drug interactions. Although many attempts to identify drug-drug interactions from real-world databases such as spontaneous reporting systems have been performed, little is known about drug-drug interactions caused by three or more drugs in polypharmacy, i.e., multiple drug-drug interactions. Therefore, we attempted to detect multiple drug-drug interactions using decision tree analysis using the Japanese Adverse Drug Event Report (JADER) database, a Japanese spontaneous reporting system. First, we used decision tree analysis to detect drug combinations that increase the risk of rhabdomyolysis in cases registered in the JADER database that used six statins. Next, the risk of three or more drug combinations that significantly increased the risk of rhabdomyolysis was validated with experiments in rats. The analysis identified a multiple drug-drug interaction signal only for pitavastatin. The reporting rate of rhabdomyolysis for pitavastatin in the JADER database was 0.09, and it increased to 0.16 in combination with allopurinol. Furthermore, the rate was even higher (0.40) in combination with valsartan. Additionally, necrosis of leg muscles was observed in some rats simultaneously treated with these three drugs, and their creatine kinase and myoglobin levels were elevated. The combination of pitavastatin, allopurinol, and valsartan should be treated with caution as a multiple drug-drug interaction. Since multiple drug-drug interactions were detected with decision tree analysis and the increased risk was verified in animal experiments, decision tree analysis is considered to be an effective method for detecting multiple drug-drug interactions.

摘要

药物-药物相互作用导致的不良药物事件可以通过避免同时使用引起相互作用的药物来预防;因此,了解引起药物-药物相互作用的药物组合非常重要。尽管已经从自发报告系统等真实世界数据库中进行了许多识别药物-药物相互作用的尝试,但对于多药治疗中(即多种药物-药物相互作用)由三种或更多种药物引起的药物-药物相互作用知之甚少。因此,我们试图使用决策树分析使用日本药物不良反应报告(JADER)数据库,一种日本自发报告系统,来检测多种药物-药物相互作用。首先,我们使用决策树分析来检测在 JADER 数据库中登记的使用六种他汀类药物的病例中增加横纹肌溶解风险的药物组合。接下来,使用大鼠实验验证了显著增加横纹肌溶解风险的三种或更多种药物组合的风险。分析仅确定了匹伐他汀的多重药物-药物相互作用信号。在 JADER 数据库中,匹伐他汀引起横纹肌溶解的报告率为 0.09,与别嘌醇合用时增加到 0.16。此外,与缬沙坦合用时甚至更高(0.40)。此外,同时用这三种药物治疗的一些大鼠出现腿部肌肉坏死,其肌酸激酶和肌红蛋白水平升高。由于决策树分析检测到了匹伐他汀、别嘌醇和缬沙坦的多重药物-药物相互作用,并且在动物实验中验证了风险增加,因此决策树分析被认为是检测多重药物-药物相互作用的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50ba/9608045/0b498891ffd3/ijmsv19p1816g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验